Education
About Us
Working with TipRanks
Follow Us
Myomo Inc (MYO)
:MYO
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.1Last Year’s EPS
-0.03Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 07, 2025
|% Change Since: -33.88%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and promising developments in the O&P channel and international markets. However, the company faced challenges in lead generation due to changes in Meta's policies and high denial rates from Medicare Advantage plans, which impacted the authorization rate and operating expenses. Despite these challenges, the company maintained its full-year guidance and showed confidence in overcoming these hurdles.Company Guidance
During Myomo's First Quarter 2025 Earnings Conference Call, the company provided several key metrics reflecting strong performance and strategic guidance despite facing some challenges. The company reported a significant year-over-year revenue growth of 162%, reaching $9.8 million, with Medicare Part B patients contributing to 60% of this revenue. It delivered 182 MyoPro units, a 100% increase compared to Q1 2024, and saw a 31% rise in the average selling price (ASP). The patient pipeline expanded by 33%, ending the quarter with nearly 1,500 patients, and 213 MyoPros were authorized and ordered. While the O&P channel revenue was $475,000, up 87% year-over-year, it reflected seasonal fluctuations. The company navigated challenges with lead generation due to changes in advertising policies by Meta, which affected lead efficiency early in the quarter, but recovered to achieve a record number of leads in April. Additionally, Myomo maintained its guidance for 2025, expecting full-year revenue to be between $50 million and $53 million, indicating growth of 54% to 66% over the previous year. The company also highlighted ongoing efforts to expand its O&P distribution channel and address insurance authorization challenges to enhance its market penetration.Record Revenue Growth in Q1 2025
Q1 revenues increased by more than 160% to $9.8 million, driven by a 100% increase in MyoPro units delivered year-over-year and a 31% increase in average selling price.
Significant Growth in Medicare Part B Revenue
Medicare Part B patients represented 60% of revenue, highlighting strong adoption and coverage for MyoPro devices.
Expansion of O&P Channel
Training completed for over 300 CPOs, up from 160, with significant progress in becoming Certified MyoPro Centers of Excellence.
International Sales Performance
International business generated over $1.3 million, primarily from Germany, indicating strong growth in international markets.
---
MYO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MYO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2025 | $4.84 | $3.36 | -30.58% |
Mar 10, 2025 | $4.17 | $5.87 | +40.77% |
Nov 06, 2024 | $4.18 | $5.02 | +20.10% |
Aug 06, 2024 | $4.20 | $3.64 | -13.33% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Myomo Inc (MYO) report earnings?
Myomo Inc (MYO) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is Myomo Inc (MYO) earnings time?
Myomo Inc (MYO) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MYO EPS forecast?
MYO EPS forecast for the fiscal quarter 2025 (Q2) is -0.1.
---